Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.76B | 2.75B | 2.74B | 2.72B | 2.68B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.76B | 2.75B | 2.74B | 2.72B | 2.68B |
| Cost of Revenue | 1.47B | 1.45B | 1.43B | 1.42B | 1.40B |
| Gross Profit | 1.29B | 1.30B | 1.31B | 1.30B | 1.28B |
| SG&A Expenses | 1.07B | 1.07B | 1.07B | 1.08B | 1.08B |
| Depreciation & Amortization | 44.60M | 22.32M | 30.67M | 33.22M | 39.65M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.59B | 2.54B | 2.53B | 2.53B | 2.52B |
| Operating Income | 175.44M | 209.04M | 203.78M | 190.59M | 156.67M |
| Income Before Tax | -101.95M | -396.02M | -391.43M | -315.96M | -329.88M |
| Income Tax Expenses | 729.00K | 29.08M | 26.81M | 25.19M | 20.85M |
| Earnings from Continuing Operations | -102.68 | -425.10 | -418.23 | -341.15 | -350.73 |
| Earnings from Discontinued Operations | -997.96M | -915.33M | -784.70M | -24.63M | -11.95M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.10B | -1.34B | -1.20B | -365.78M | -362.69M |
| EBIT | 175.44M | 209.04M | 203.78M | 190.59M | 156.67M |
| EBITDA | 389.96M | 375.39M | 367.64M | 358.93M | 337.95M |
| EPS Basic | -14.30 | -17.42 | -15.64 | -4.76 | -4.73 |
| Normalized Basic EPS | 0.39 | 0.66 | 0.62 | 0.67 | 0.38 |
| EPS Diluted | -14.31 | -17.42 | -15.64 | -4.76 | -4.72 |
| Normalized Diluted EPS | 0.39 | 0.66 | 0.62 | 0.67 | 0.38 |
| Average Basic Shares Outstanding | 308.19M | 308.23M | 308.04M | 307.83M | 306.88M |
| Average Diluted Shares Outstanding | 308.19M | 308.23M | 309.42M | 309.21M | 308.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |